vTv Therapeutics Inc. SEC filings VTVT
vTv Therapeutics Inc. has 601 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 20, 2025 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| D | Filing | Mar 7, 2024 | — |
| CT ORDER | Filing | Jul 22, 2021 | — |
| EFFECT | Filing | Jun 11, 2021 | — |
| CORRESP | Letter to the SEC | Jun 9, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2021 | — |
| EFFECT | Filing | Apr 20, 2021 | — |
| CORRESP | Letter to the SEC | Apr 16, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2021 | — |
| CT ORDER | Filing | Feb 18, 2021 | — |
| EFFECT | Filing | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 4, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2020 | — |
| D | Filing | Jan 17, 2020 | — |
| D | Filing | Oct 15, 2019 | — |
| EFFECT | Filing | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jul 11, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2019 | — |
| D | Filing | Jul 9, 2019 | — |
| D | Filing | Jan 4, 2019 | — |
| CT ORDER | Filing | Sep 12, 2018 | — |
| D | Filing | Aug 10, 2018 | — |
| CT ORDER | Filing | Apr 6, 2018 | — |
| EFFECT | Filing | Mar 19, 2018 | — |
| CORRESP | Letter to the SEC | Mar 15, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2018 | — |
| CORRESP | Letter to the SEC | Jan 9, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2017 | — |
| D | Filing | Dec 19, 2017 | — |
| CT ORDER | Filing | Mar 27, 2017 | — |
| CT ORDER | Filing | Jul 31, 2015 | — |
| CERTNAS | Auto-generated paper document | Jul 30, 2015 | — |
| 8-A12B | Form 8-a12b | Jul 30, 2015 | — |
| EFFECT | Filing | Jul 29, 2015 | — |
| CORRESP | Letter to the SEC | Jul 28, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2015 | — |
| CORRESP | Letter to the SEC | Jul 14, 2015 | — |
| CORRESP | Letter to the SEC | Jul 13, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2015 | — |
| CORRESP | Letter to the SEC | Jul 8, 2015 | — |
| CORRESP | Letter to the SEC | Jul 6, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2015 | — |
| DRSLTR | Filing | May 14, 2015 | — |
| DRS | Filing | May 14, 2015 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VTVT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- High Point, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1641489
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.